Document is current

Any future updates will be listed below

Health technology assessment of drugs for rare diseases: insights, trends, and reasons for negative recommendations from the CADTH common drug review

Crossref DOI link: https://doi.org/10.1186/s13023-016-0539-3

Published Online: 2016-12-01

Published Print: 2016-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark